Article Text

Download PDFPDF
Response to: ‘OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE’ by Mizuno et al
  1. Paola Conigliaro1,
  2. Massimo Cesareo2,
  3. Maria Sole Chimenti1,
  4. Paola Triggianese1,
  5. Claudia Canofari1,
  6. Gianluca Aloe2,
  7. Carlo Nucci2,
  8. Roberto Perricone1
  1. 1 Rheumatology, Allergology and Clinical Immunology, Department of 'Medicina dei Sistemi', University of Rome Tor Vergata, Rome, Italy
  2. 2 Ophthalmology Unit, Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy
  1. Correspondence to Dr Paola Conigliaro, Rheumatology, Allergology and Clinical Immunology, Department of 'Medicina dei Sistemi', University of Rome Tor Vergata, Rome 00133, Italy; paola.conigliaro{at}uniroma2.it

Statistics from Altmetric.com

We read with interest the letter titled ‘OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE’ by Mizuno et al published in the Annals of the Rheumatic Diseases.1 In the letter, the authors pointed out that retinal vasculitis is an important manifestation of systemic lupus erythematosus (SLE), even if the patient is asymptomatic. Furthermore, they claim that patients with abnormal eye findings should be closely followed. We agree with Mizuno et al considering the non-invasive nature of optical coherence tomography angiography (OCTA), the reliability, and that high-resolution images of the retinal vasculature can be obtained approaching histology-level resolution. OCTA seems to …

View Full Text

Footnotes

  • Handling editor Josef S Smolen

  • PC and MC contributed equally.

  • Correction notice This article has been corrected since it published Online First. The author names have been updated.

  • Contributors All the authors contributed to the correspondence response.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles